Cashman Kevin D, Dowling Kirsten G, Škrabáková Zuzana, Gonzalez-Gross Marcela, Valtueña Jara, De Henauw Stefaan, Moreno Luis, Damsgaard Camilla T, Michaelsen Kim F, Mølgaard Christian, Jorde Rolf, Grimnes Guri, Moschonis George, Mavrogianni Christina, Manios Yannis, Thamm Michael, Mensink Gert Bm, Rabenberg Martina, Busch Markus A, Cox Lorna, Meadows Sarah, Goldberg Gail, Prentice Ann, Dekker Jacqueline M, Nijpels Giel, Pilz Stefan, Swart Karin M, van Schoor Natasja M, Lips Paul, Eiriksdottir Gudny, Gudnason Vilmundur, Cotch Mary Frances, Koskinen Seppo, Lamberg-Allardt Christel, Durazo-Arvizu Ramon A, Sempos Christopher T, Kiely Mairead
Cork Centre for Vitamin D and Nutrition Research, School of Food and Nutritional Sciences, Department of Medicine, and
Cork Centre for Vitamin D and Nutrition Research, School of Food and Nutritional Sciences.
Am J Clin Nutr. 2016 Apr;103(4):1033-44. doi: 10.3945/ajcn.115.120873. Epub 2016 Feb 10.
Vitamin D deficiency has been described as being pandemic, but serum 25-hydroxyvitamin D [25(OH)D] distribution data for the European Union are of very variable quality. The NIH-led international Vitamin D Standardization Program (VDSP) has developed protocols for standardizing existing 25(OH)D values from national health/nutrition surveys.
This study applied VDSP protocols to serum 25(OH)D data from representative childhood/teenage and adult/older adult European populations, representing a sizable geographical footprint, to better quantify the prevalence of vitamin D deficiency in Europe.
The VDSP protocols were applied in 14 population studies [reanalysis of subsets of serum 25(OH)D in 11 studies and complete analysis of all samples from 3 studies that had not previously measured it] by using certified liquid chromatography-tandem mass spectrometry on biobanked sera. These data were combined with standardized serum 25(OH)D data from 4 previously standardized studies (for a total n= 55,844). Prevalence estimates of vitamin D deficiency [using various serum 25(OH)D thresholds] were generated on the basis of standardized 25(OH)D data.
An overall pooled estimate, irrespective of age group, ethnic mix, and latitude of study populations, showed that 13.0% of the 55,844 European individuals had serum 25(OH)D concentrations <30 nmol/L on average in the year, with 17.7% and 8.3% in those sampled during the extended winter (October-March) and summer (April-November) periods, respectively. According to an alternate suggested definition of vitamin D deficiency (<50 nmol/L), the prevalence was 40.4%. Dark-skinned ethnic subgroups had much higher (3- to 71-fold) prevalence of serum 25(OH)D <30 nmol/L than did white populations.
Vitamin D deficiency is evident throughout the European population at prevalence rates that are concerning and that require action from a public health perspective. What direction these strategies take will depend on European policy but should aim to ensure vitamin D intakes that are protective against vitamin D deficiency in the majority of the European population.
维生素D缺乏已被描述为一种普遍现象,但欧盟的血清25-羟基维生素D[25(OH)D]分布数据质量参差不齐。由美国国立卫生研究院牵头的国际维生素D标准化项目(VDSP)已制定方案,用于规范来自国家健康/营养调查的现有25(OH)D值。
本研究将VDSP方案应用于来自具有代表性的欧洲儿童/青少年及成人/老年人人群的血清25(OH)D数据,这些人群覆盖了相当大的地理范围,以更好地量化欧洲维生素D缺乏的患病率。
通过使用经认证的液相色谱-串联质谱法对生物样本库中的血清进行检测,将VDSP方案应用于14项人群研究[对11项研究中的血清25(OH)D子集进行重新分析,对3项之前未检测过的研究中的所有样本进行完整分析]。这些数据与来自4项之前已标准化研究的标准化血清25(OH)D数据相结合(总计n = 55,844)。根据标准化的25(OH)D数据,得出维生素D缺乏的患病率估计值[使用各种血清25(OH)D阈值]。
总体汇总估计显示,无论研究人群的年龄组、种族构成和纬度如何,在这55,844名欧洲人中,有13.0%的人年平均血清25(OH)D浓度<30 nmol/L,在冬季延长期间(10月至次年3月)和夏季(4月至11月)采样的人群中,这一比例分别为17.7%和8.3%。根据维生素D缺乏的另一种建议定义(<50 nmol/L),患病率为40.4%。肤色较深的种族亚组血清25(OH)D<30 nmol/L的患病率比白人群体高得多(3至71倍)。
维生素D缺乏在整个欧洲人群中很明显,患病率令人担忧,从公共卫生角度来看需要采取行动。这些策略的方向将取决于欧洲政策,但应旨在确保大多数欧洲人群的维生素D摄入量能预防维生素D缺乏。